AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1343613
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg b.i.d. lovastatin (Mevacor)
Trial: 31144304
Drug: PPARÎ´ agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPARÎ´ agonist GW501516
Trial: 31144304
Drug: PPARÎ´ antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPARÎ´ antagonist GSK0660
Trial: 23060037
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg daily)
Trial: 17465970
Drug: Naproxen 10
RxNorm normalized name: naproxen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 10 mg/kg
Trial: 17465970
Drug: Pethidine 1
RxNorm normalized name: Pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pethidine 1 mg/kg i.v.
Trial: 17465970
Drug: Naproxen, Paracetamol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen, Paracetamol, and Placebo with Pethidine
Trial: 11257737
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic (n = 24)
Trial: 11257737
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of antibiotics (n = 35)
Trial: 11257737
Drug: 5-day course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day course of antibiotics (n = 31)
Trial: 31998285
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not receiving antibiotics)
Trial: 9439944
Drug: Valproate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valproate (1 g per day) for 8 weeks
Trial: 9439944
Drug: Flunarizine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine (10 mg per day) for 8 weeks
Trial: 2827920
Drug: nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: nedocromil sodium (1% nasal spray)
Trial: 28803502
Drug: 60 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 µg recombinant hepatitis B vaccine
Trial: 28803502
Drug: 20 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 µg recombinant hepatitis B vaccine
Trial: 23452187
Drug: Intravesical chemotherapy
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical chemotherapy
Trial: 9311953
Drug: Control cereal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control cereal (≤3 g soluble fiber/d)
Trial: 2859185
Drug: Felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 5 mg thrice daily
Trial: 2859185
Drug: Felodipine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 7.5 mg twice daily
Trial: 24717369
Drug: Raised C-reactive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raised C-reactive protein (CRP; >5 mg/L)
Trial: 24717369
Drug: Modified relative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified relative dose response values
Trial: 14709290
Drug: topical betaxolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: topical betaxolol 0.5% solution
Trial: 10870778
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose oral azithromycin 1 g
Trial: 10870778
Drug: Seven-day doxycycline
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Seven-day doxycycline 100 mg twice daily
Trial: 9586517
Drug: Real Low-Level
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real Low-Level Laser therapy (830 nm Ga‐Al‐As Laser, 4 joules, 3 sessions)
Trial: 9586517
Drug: Real Low-Level
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real Low-Level Laser therapy
Trial: 8436152
Drug: Zabicipril 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zabicipril 0.5 mg, 1 mg, or 2.5 mg
Trial: 3464039
Drug: Ibuprofen (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (single dose)
Trial: 29908319
Drug: Free vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free vitamin D3 concentrations < 5pg/mL
Trial: 29908319
Drug: Free vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free vitamin D3 concentrations 5 to 9pg/mL
Trial: 29908319
Drug: Free vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free vitamin D3 concentrations > 9pg/mL
Trial: 19941048
Drug: Telephone‐administered Cognitive‐Behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone‐administered Cognitive‐Behavioral Therapy (T‐CBT)
Trial: 19941048
Drug: Telephone‐administered Emotion‐Focused
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone‐administered Emotion‐Focused Therapy (T‐EFT)
Trial: 10086671
Drug: 10 days
RxNorm normalized name: AlleRx 10-day Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 days of omeprazole 20 mg b.d., amoxycillin 500 mg t.d.s., and metronidazole 400 mg t.d.s. (OAM)
Trial: 10086671
Drug: 10 days
RxNorm normalized name: AlleRx 10-day Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 days of omeprazole 20 mg b.d., amoxycillin 500 mg t.d.s., and metronidazole 400 mg t.d.s. (OAM) plus compliance enhancing measures
Trial: 1896092
Drug: 1 alpha-OH-D3
RxNorm normalized name: 1-alpha-25-Dihydroxyvitamin D3
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1 alpha-OH-D3 and calcium carbonate (existing treatment)
Trial: 6367434
Drug: Metoclopramide, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide, 10 mg four times a day
Trial: 24755124
Drug: FDC tablet
RxNorm normalized name: DYE FDC BLUE #1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC tablet with food
Trial: 24755124
Drug: FDC tablet
RxNorm normalized name: DYE FDC BLUE #1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC tablet without food
Trial: 24755124
Drug: FDC tablets
RxNorm normalized name: DYE FDC BLUE #1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC tablets with normal dissolution characteristics
Trial: 24755124
Drug: FDC tablets
RxNorm normalized name: DYE FDC BLUE #1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC tablets with slower dissolution characteristics
Trial: 23711168
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy for pain and insomnia (CBT-PI)
Trial: 25365778
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy for pain (CBT-P)
Trial: 20211222
Drug: Anti-cholinergic bronchodilator
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-cholinergic bronchodilator (ipratropium bromide)
Trial: 16633103
Drug: Mesalazine 1.6
RxNorm normalized name: Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine 1.6 g/d
Trial: 16633103
Drug: Mesalazine 1.6
RxNorm normalized name: Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine 1.6 g/d + Lactobacillus casei DG 16 billion/d for 15 d/mo
Trial: 8930427
Drug: Regimen A
RxNorm normalized name: CHLOROXYLENOL 5 g in 1000 mL TOPICAL SOAP [REGIMEN ANTIMICROBIAL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen A (granules from a 30‐mg capsule mixed with apple juice and administered through a nasogastric tube)
Trial: 7585848
Drug: Regimen B
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen B (an intact 30‐mg capsule)
Trial: 1528957
Drug: Imipramine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine plus Mianserin (30 mg daily)
Trial: 3987221
Drug: Controlled-release pseudoephedrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release pseudoephedrine formulations
Trial: 3987221
Drug: Optimal controlled-release
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal controlled-release formulation from single-dose study
Trial: 3987221
Drug: Immediate-release pseudoephedrine
RxNorm normalized name: pseudoephedrine Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release pseudoephedrine hydrochloride
Trial: 3987221
Drug: Reference pseudoephedrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference pseudoephedrine hydrochloride syrup
Trial: 25877234
Drug: Bur preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bur preparation
Trial: 25877234
Drug: Both methods
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both methods (Er:YAG laser and Bur preparation)
Trial: 8618434
Drug: Fludarabine- and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludarabine- and high-dose cytarabine-containing regimens
Trial: 6434367
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of LactAid added to milk
Trial: 29902286
Drug: Sequential strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential strategy (letrozole followed by tamoxifen)
Trial: 23442547
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (compensating extraction of the upper first permanent molar)
Trial: 21042881
Drug: 20% mannitol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% mannitol (1.0 g/kg)
Trial: 21042881
Drug: 23.4% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23.4% saline (0.686 mL/kg)
Trial: 16608860
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy during ICU stay
Trial: 16608860
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy during ICU stay (with at least 3 days of insulin therapy)
Trial: 2542427
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous insulin infusion (CSII) therapy
Trial: 1914373
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral nifedipine
Trial: 1290431
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg intravenous hydralazine
Trial: 6746322
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin A (10,000 micrograms/d) for 4 weeks
Trial: 15577414
Drug: 5% lidocaine
RxNorm normalized name: LIDOCAINE 5 g in 100 g TOPICAL CREAM [Healcome Tattoo Numbing Cream 5% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% lidocaine gel
Trial: 19571802
Drug: Atorvastatin (34
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (34 ± 26 mg/day)
Trial: 19571802
Drug: Morning dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dosing of atorvastatin
Trial: 9133199
Drug: Indomethacin suppository
RxNorm normalized name: indomethacin Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin suppository 100 mg
Trial: 9133199
Drug: Ketorolac IM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac IM injection 30 mg
Trial: 2251987
Drug: Urokinase 2
RxNorm normalized name: UROKINASE 250000UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urokinase 2 million units as an intravenous bolus before hospital admission (group A)
Trial: 2251987
Drug: Urokinase 2
RxNorm normalized name: UROKINASE 250000UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urokinase 2 million units as an intravenous bolus after hospital admission (group B)
Trial: 26715771
Drug: Sham therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham therapy (5% of P(Imax)) for 6 weeks
Trial: 23545807
Drug: Daikenchuto (DKT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daikenchuto (DKT) 2.5 g
Trial: 23545807
Drug: Daikenchuto (DKT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daikenchuto (DKT) 5 g
Trial: 23545807
Drug: Daikenchuto (DKT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daikenchuto (DKT) 10 g
Trial: 21753726
Drug: Intranasal application
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal application of xenon
Trial: 9316325
Drug: Conventional postoperative
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional postoperative analgesia of intravenous (i.v.) meperidine HCl (Demerol)
Trial: 9316325
Drug: Preemptive analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive analgesia using epidural infusion of local anesthetics plus ketamine and morphine during surgery, and intermittent epidural morphine infusion for postoperative pain control when necessary, along with i.v. Demerol as in Group A
Trial: 3567016
Drug: Promethazine 20
RxNorm normalized name: promethazine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine 20 mg
Trial: 3567016
Drug: Promethazine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine 40 mg
Trial: 31571349
Drug: Combined IVIg
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined IVIg (2g/kg loading dose, 1g/kg maintenance every 3 weeks) and IVMP (1g every 3 weeks for 18 weeks); cumulative steroid dose 7g
Trial: 31331390
Drug: Atrophic gastritis
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atrophic gastritis (PGI < 30 μg/L or PGI: PGII < 3.0)
Trial: 30514858
Drug: CagA antibody
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CagA antibody positive
Trial: 22681259
Drug: Capsaicin 0.1%
RxNorm normalized name: CAPSAICIN 0.1% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin 0.1% hydrogel patch
Trial: 22681259
Drug: Control hydrogel
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control hydrogel patch without capsaicin
Trial: 20493191
Drug: Higher fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher fat (HF) cream cheese
Trial: 20493191
Drug: Lower fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower fat (LF) cream cheese
Trial: 17568412
Drug: 300 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/kg i.v. glucose
Trial: 15743346
Drug: On medications
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On medications for heartburn
Trial: 15743346
Drug: Off medications
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Off medications for 1 week while symptomatic
Trial: 15743346
Drug: On and
RxNorm normalized name: beef,iron and wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On and off antireflux medications
Trial: 15743346
Drug: Off medications
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Off medications for patients with comorbid conditions
Trial: 12036207
Drug: Thermal water
RxNorm normalized name: thermal water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thermal water from Cserkeszölö (active treatment)
Trial: 12036207
Drug: Tap water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tap water (placebo treatment)
Trial: 9951980
Drug: High titer
RxNorm normalized name: Immune Globulin (Human) containing high titers of West Nile virus antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High titer measles vaccine
Trial: 9951980
Drug: High titer
RxNorm normalized name: Immune Globulin (Human) containing high titers of West Nile virus antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High titer measles vaccine with rash
Trial: 9951980
Drug: High titer
RxNorm normalized name: Immune Globulin (Human) containing high titers of West Nile virus antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High titer measles vaccine without rash
Trial: 1824203
Drug: Lovastatin (L)
RxNorm normalized name: Lovastatin
DrugBank: Lovastatin (DB00227)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lovastatin (L)
Trial: 29081160
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (10 mg/kg loading dose and 10 mg·kg(‐1)·h(‐1) infusion dose)
Trial: 25143294
Drug: VLNC +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VLNC + PLA (very low nicotine content cigarettes with placebo patches)
Trial: 25143294
Drug: VLNC +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VLNC + NIC (very low nicotine content cigarettes with nicotine patches totaling 42mg)
Trial: 21324825
Drug: Insulin glulisine
RxNorm normalized name: Insulin Glulisine
DrugBank: Insulin glulisine (DB01309)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin glulisine 3 times daily
Trial: 21324825
Drug: Insulin glulisine
RxNorm normalized name: Insulin Glulisine
DrugBank: Insulin glulisine (DB01309)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin glulisine 2 times daily
Trial: 21324825
Drug: Insulin glulisine
RxNorm normalized name: Insulin Glulisine
DrugBank: Insulin glulisine (DB01309)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin glulisine 1 time daily
Trial: 21324825
Drug: Insulin glulisine
RxNorm normalized name: Insulin Glulisine
DrugBank: Insulin glulisine (DB01309)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin glulisine 1 or 2 times daily
Trial: 19147693
Drug: Placebo (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (initial 12 weeks) followed by open active treatment as clinically indicated
Trial: 19147693
Drug: Active treatments
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatments (fluoxetine, CBT, combination treatment)
Trial: 17468868
Drug: Fondaparinux 2.5
RxNorm normalized name: FONDAPARINUX 2.5MG/0.5ML INJ SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux 2.5 mg
Trial: 9496329
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of recombinant human LH and FSH
Trial: 8110566
Drug: Group B10
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B10 (10 micrograms kg‐1 bolus dose)
Trial: 8110566
Drug: Group B20
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B20 (20 micrograms kg‐1 bolus dose)
Trial: 3349887
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (6 g daily)
Trial: 3349887
Drug: Aluminum hydroxide
RxNorm normalized name: Aluminum Hydroxide
DrugBank: Aluminum hydroxide (DB06723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum hydroxide (7.2 g daily)
Trial: 28993394
Drug: Shape‐Up following
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shape‐Up following cancer treatment programme (12 hours over 8 weeks)
Trial: 25256304
Drug: General practitioners'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General practitioners' use of argumentation to support treatment advice
Trial: 19898884
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training (breathing and aerobic exercises) for 1.5 h, 3 days weekly for 12 weeks
Trial: 16611272
Drug: rifaximin 800
RxNorm normalized name: Rifaximin
DrugBank: Rifaximin (DB01220)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rifaximin 800 mg b.d.
Trial: 16611272
Drug: rifaximin 800
RxNorm normalized name: Rifaximin
DrugBank: Rifaximin (DB01220)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rifaximin 800 mg o.d. + placebo
Trial: 14708688
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg daily lamivudine therapy
Trial: 11056097
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens (0.625 mg) combined with medroxyprogesterone acetate (2.5 mg) daily
Trial: 1507822
Drug: Plasmapheresis (PA)
RxNorm normalized name: HAEMO-PAK UNIT FOR PLASMAPHERESIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasmapheresis (PA) as a treatment
Trial: 6742082
Drug: Timolol maleate
RxNorm normalized name: Timolol Maleate
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol maleate 0.5% eyedrops (used twice a day)
Trial: 6742082
Drug: Indomethacin 25
RxNorm normalized name: indomethacin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 25 mg (three times a day, given orally)
Trial: 20019606
Drug: n-3 FA
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 FA as a treatment option
Trial: 17181846
Drug: Valdecoxib 40
RxNorm normalized name: valdecoxib 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib 40 mg administered pre- and postoperatively